Why Stop Now? Extended and Continuous Regimens of Combined Hormonal Contraceptive Methods

被引：18

作者：

Benson, Lyndsey S. ^{[1
]}

Micks, Elizabeth A. ^{[1
]}

机构：

[1] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA

来源：

OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA | 2015年 / 42卷 / 04期

关键词：

Combined hormonal contraception; Combined oral contraceptive pills; Extended contraceptive use; Continuous contraceptive use; Ovulation suppression; Bleeding profile with contraception; Contraceptive vaginal ring; Contraceptive transdermal patch; CYCLIC ORAL-CONTRACEPTIVES; LEVONORGESTREL/ETHINYL ESTRADIOL; BLEEDING PROFILE; VAGINAL RING; OPEN-LABEL; PILL; FREQUENCY; SAFETY; ACCEPTABILITY; ENDOMETRIOSIS;

D O I：

10.1016/j.ogc.2015.07.009

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Combined hormonal contraceptives (CHCs) have traditionally been prescribed in 28-day cycles, with 21 days of active hormones followed by a 7-day hormone-free interval. Extended and continuous CNC regimens, defined as regimens with greater than 28 days of active hormones, offer many benefits, including a decrease in estrogen-withdrawal symptoms and likely greater efficacy because of more reliable ovulation suppression. Bleeding profiles are favorable, and unscheduled bleeding decreases over time with these regimens. Extended and continuous regimens of combined oral contraceptives and the contraceptive vaginal ring are safe and have high user acceptability and satisfaction. However, despite numerous benefits, extended and continuous CHC regimens are underused.

引用

页码：669 / +

页数：15

共 42 条

[1] Long-term safety of an extended-cycle oral contraceptive (Seasonate): A 2-year multicenter open-label extension trial [J].

Anderson, F. D. ;

Gibbons, William ;

Portman, David .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (01) :92-96

[2] A multicenter, randomized study of an extended cycle oral contraceptive [J].

Anderson, FD ;

Hait, H .

CONTRACEPTION, 2003, 68 (02) :89-96

[3] Endometrial effects of a 91-day extended-regimen oral contraceptive with low-dose estrogen in place of placebo [J].

Anderson, Freedolph D. ;

Feldman, Robert ;

Reape, Kathleen Z. .

CONTRACEPTION, 2008, 77 (02) :91-96

[4] Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives [J].

Andrist, LC ;

Arias, RD ;

Nucatola, D ;

Kaunitz, AM ;

Musselman, BL ;

Reiter, S ;

Boulanger, J ;

Dominguez, L ;

Emmert, S .

CONTRACEPTION, 2004, 70 (05) :359-363

[5] Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results [J].

Archer, David F. ;

Jensen, Jeffrey T. ;

Johnson, Julia V. ;

Borisute, Hannah ;

Grubb, Gary S. ;

Constantine, Ginger D. .

CONTRACEPTION, 2006, 74 (06) :439-445

[6] Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use [J].

Birtch, RL ;

Olatunbosun, OA ;

Pierson, RA .

CONTRACEPTION, 2006, 73 (03) :235-243

[7] Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen [J].

Coffee, Andrea L. ;

Sulak, Patricia J. ;

Kuehl, Thomas J. .

CONTRACEPTION, 2007, 75 (06) :444-449

[8] Work loss associated with increased menstrual loss in the United States [J].

Côté, I ;

Jacobs, P ;

Cumming, D .

OBSTETRICS AND GYNECOLOGY, 2002, 100 (04) :683-687

[9] COMPARATIVE-STUDY ON INTERMITTENT VERSUS CONTINUOUS USE OF A CONTRACEPTIVE PILL ADMINISTERED BY VAGINAL ROUTE [J].

COUTINHO, EM ;

ODWYER, E ;

BARBOSA, IC ;

ZHIPING, G ;

SHAABAN, MM ;

ABOULOYOON, M ;

ALEEM, HA .

CONTRACEPTION, 1995, 51 (06) :355-358

[10]

Curtis KM, 2013, MMWR RECOMM REP, V62, P1

← 1 2 3 4 5 →